Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 11Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 12Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Lung Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia, Megakaryoblastic, Acute 3Fallopian Tube Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Obesity 2Neoplasms 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Hodgkin Disease 2Congenital Abnormalities 2Colonic Neoplasms 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Thymus Neoplasms 1Thymoma 1Sezary Syndrome 1Sertoli-Leydig Cell Tumor 1Salivary Gland Neoplasms 1

Interventions

Taxes 1Paclitaxel 1Metformin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Has results × Endometrial Adenocarcinoma × Clear all
NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

GOG Foundation

Phase 2/3 Unknown
469 enrolled 16 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡